CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (241,419)	$ (56,858)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,220	3,449
Stock-based compensation	140,381	31,263
Amortization of debt discount (accretion of debt premium) and issuance costs	3,362	15,724
Amortization of finite-lived intangible assets	56,209
Amortization of premium (accretion of discount) on investments in marketable debt securities	10,039	1,970
Non-cash operating lease expense	6,307	2,635
Provision for losses on acquired card receivables	15,621
Deferred income taxes	(4,691)	(333)
Changes in assets and liabilities:
Accounts receivable	(5,846)	(5,332)
Prepaid expenses and other current assets	(2,966)	(6,149)
Other assets	(968)	(11,799)
Accounts payable	(4,435)	927
Other accruals and current liabilities	12,665	58
Operating lease liabilities	(5,591)	7,782
Other long-term liabilities	302	576
Deferred revenue	5,191	2,924
Net cash used in operating activities	(7,619)	(13,163)
Cash flows from investing activities:
Cash paid for acquisition, net of acquired cash and cash equivalents	(144,541)
Purchases of corporate and customer fund short-term investments	(2,176,127)	(1,486,025)
Proceeds from maturities of corporate and customer fund short-term investments	1,308,650	830,933
Proceeds from sale of corporate and customer fund short-term investments	50,744	119,072
Increase in other receivables included in funds held for customers	(13,547)	(9,072)
Increase in acquired card receivables	(89,909)
Purchases of property and equipment	(3,758)	(17,062)
Capitalization of internal-use software costs	(7,409)	(1,038)
Net cash used in investing activities	(1,075,897)	(563,192)
Cash flows from financing activities:
Proceeds from issuance of common stock upon public offering, net of underwriting discounts and other offering costs	1,341,122
Proceeds from issuance of convertible senior notes, net of discounts and issuance costs	560,075	1,129,379
Purchase of capped call	(37,893)	(87,860)
Increase in customer fund deposits liability	834,942	285,590
Payments of line of credit borrowings		(2,300)
Proceeds from exercise of stock options	29,116	23,034
Proceeds from issuance of common stock under the employee stock purchase plan	12,849	8,864
Other	(351)	(664)
Net cash provided by financing activities	2,739,860	1,356,043
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents	1,656,344	779,688
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period	1,809,692	1,592,377
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	3,466,036	2,372,065
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:
Cash and cash equivalents	1,639,371	1,223,724
Restricted cash included in other current assets	$ 28,343	$ 35
Restricted Cash, Current, Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssetsCurrent	us-gaap:OtherAssetsCurrent
Restricted cash included in other assets	$ 6,724
Restricted Cash, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Restricted cash and restricted cash equivalents included in funds held for customers	$ 1,791,598	$ 1,148,306
Total cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	$ 3,466,036	$ 2,372,065